|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of ABCC4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
EXP ISO |
andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]] andrographolide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] andrographolide results in decreased expression of ACTA2 mRNA; andrographolide results in decreased expression of ACTA2 protein andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]; NFE2L2 gene mutant form inhibits the reaction [andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]] |
CTD |
PMID:29355602 PMID:31128153 PMID:31706003 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
|
|
G |
ADH7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of ADH7 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:99,412,263...99,435,342
Ensembl chr 4:99,412,261...99,435,510
|
|
G |
ANKRD1 |
ankyrin repeat domain 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
|
|
G |
AOX3P |
aldehyde oxidase 3, pseudogene |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of AOX3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:200,695,723...200,738,781
Ensembl chr 2:200,678,233...200,732,539
|
|
G |
ATF2 |
activating transcription factor 2 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [cobaltous chloride results in increased expression of ATF2 protein modified form]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of ATF2 protein modified form]] |
CTD |
PMID:29165873 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
B4GALT1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
EXP |
andrographolide results in increased expression of B4GALT1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,104,082...33,167,356
|
|
G |
BAD |
BCL2 associated agonist of cell death |
increases expression |
EXP |
andrographolide results in increased expression of BAD protein |
CTD |
PMID:35917943 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
affects folding increases expression multiple interactions |
EXP |
andrographolide affects the folding of BAX protein andrographolide results in increased expression of BAX mRNA; andrographolide results in increased expression of BAX protein [andrographolide co-treated with Cisplatin] results in increased expression of BAX mRNA; andrographolide promotes the reaction [Cisplatin results in increased expression of BAX protein]; Fluorouracil promotes the reaction [andrographolide affects the folding of BAX protein] |
CTD |
PMID:19097688 PMID:23845849 PMID:24563380 PMID:35917943 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBC3 |
BCL2 binding component 3 |
increases expression |
EXP |
andrographolide results in increased expression of BBC3 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions |
EXP |
andrographolide results in decreased expression of BCL2 protein [andrographolide co-treated with Cisplatin] results in decreased expression of BCL2 mRNA |
CTD |
PMID:23845849 PMID:24563380 PMID:35917943 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BHMT |
betaine--homocysteine S-methyltransferase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of BHMT mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
|
|
G |
BID |
BH3 interacting domain death agonist |
multiple interactions increases expression |
ISO EXP |
andrographolide inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]; andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]] [andrographolide co-treated with Cisplatin] results in increased expression of BID mRNA andrographolide results in increased expression of BID mRNA; andrographolide results in increased expression of BID protein |
CTD |
PMID:20946909 PMID:24563380 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
multiple interactions increases expression |
EXP |
[andrographolide co-treated with TNF protein] results in decreased expression of BIRC3 mRNA andrographolide results in increased expression of BIRC3 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
decreases expression |
EXP |
andrographolide results in decreased expression of BIRC5 protein |
CTD |
PMID:23845849 |
|
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
|
|
G |
BLVRB |
biliverdin reductase B |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of BLVRB mRNA |
CTD |
PMID:19737545 |
|
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
|
|
G |
CASP3 |
caspase 3 |
increases activity increases cleavage multiple interactions increases expression |
EXP ISO |
andrographolide results in increased activity of CASP3 protein andrographolide results in increased cleavage of CASP3 protein andrographolide inhibits the reaction [TGFB1 protein results in decreased cleavage of CASP3 protein] andrographolide results in increased expression of CASP3 mRNA [andrographolide co-treated with Cisplatin] results in increased expression of CASP3 mRNA; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein] andrographolide inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]; andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]] |
CTD |
PMID:19097688 PMID:20946909 PMID:24563380 PMID:31706003 PMID:35917943 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases activity increases expression multiple interactions |
EXP ISO |
andrographolide results in increased activity of CASP8 protein andrographolide results in increased expression of CASP8 mRNA [andrographolide co-treated with Cisplatin] results in increased expression of CASP8 mRNA; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; CASP8 results in increased susceptibility to [andrographolide co-treated with Fluorouracil]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP8 protein] andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP8 protein] |
CTD |
PMID:19097688 PMID:20946909 PMID:24563380 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases activity increases expression multiple interactions |
EXP ISO |
andrographolide results in increased activity of CASP9 protein andrographolide results in increased expression of CASP9 mRNA andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]; andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] [andrographolide co-treated with Cisplatin] results in increased expression of CASP9 mRNA; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein] |
CTD |
PMID:19097688 PMID:20946909 PMID:24563380 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[andrographolide co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; andrographolide inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] andrographolide inhibits the reaction [Freund's Adjuvant results in decreased activity of CAT protein] |
CTD |
PMID:26485141 PMID:32061742 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CBR1 |
carbonyl reductase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166
|
|
G |
CBR3 |
carbonyl reductase 3 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR3 mRNA andrographolide results in increased expression of CBR3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO EXP |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCL2 mRNA andrographolide results in increased expression of CCL2 mRNA |
CTD |
PMID:19737545 PMID:35724838 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
increases expression |
EXP |
andrographolide results in increased expression of CCL20 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCN2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCN2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CCNA2 |
cyclin A2 |
multiple interactions decreases expression |
EXP |
andrographolide inhibits the reaction [CCNA2 protein binds to CDK2 protein] andrographolide results in decreased expression of CCNA2 protein |
CTD |
PMID:18619950 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions decreases expression |
EXP |
andrographolide inhibits the reaction [CCND1 protein binds to CDK4 protein] andrographolide results in decreased expression of CCND1 protein |
CTD |
PMID:18619950 PMID:23845849 PMID:35917943 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE1 |
cyclin E1 |
decreases expression multiple interactions |
EXP ISO |
andrographolide results in decreased expression of CCNE1 protein andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein] |
CTD |
PMID:23845849 PMID:27475717 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CDH1 |
cadherin 1 |
multiple interactions increases expression |
EXP ISO |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein]] andrographolide results in increased expression of CDH1 protein |
CTD |
PMID:31128153 PMID:35917943 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDH17 |
cadherin 17 |
decreases expression multiple interactions |
ISO |
andrographolide results in decreased expression of CDH17 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CDH17 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 8:94,127,162...94,217,278
Ensembl chr 8:94,127,162...94,217,303
|
|
G |
CDH2 |
cadherin 2 |
multiple interactions decreases expression |
EXP ISO |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein]] andrographolide results in decreased expression of CDH2 protein |
CTD |
PMID:31128153 PMID:35917943 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
decreases expression multiple interactions |
EXP ISO |
andrographolide results in decreased expression of CDK2 protein andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein] andrographolide inhibits the reaction [CCNA2 protein binds to CDK2 protein] |
CTD |
PMID:18619950 PMID:27475717 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDK4 |
cyclin dependent kinase 4 |
multiple interactions decreases expression |
EXP |
andrographolide inhibits the reaction [CCND1 protein binds to CDK4 protein] andrographolide results in decreased expression of CDK4 protein |
CTD |
PMID:18619950 |
|
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
EXP |
andrographolide results in increased expression of CDKN1A protein |
CTD |
PMID:18619950 PMID:23845849 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CEBPA |
CCAAT enhancer binding protein alpha |
multiple interactions |
ISO |
andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] |
CTD |
PMID:27475717 |
|
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
multiple interactions |
ISO |
andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein] |
CTD |
PMID:27475717 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
|
|
G |
CES3 |
carboxylesterase 3 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CES3 mRNA andrographolide results in increased expression of CES3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr16:66,961,266...66,975,149
Ensembl chr16:66,961,245...66,975,149
|
|
G |
CISH |
cytokine inducible SH2 containing protein |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CISH mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774
|
|
G |
CNN2 |
calponin 2 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CNN2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr19:1,026,608...1,039,065
Ensembl chr19:1,026,586...1,039,068
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions decreases expression |
EXP ISO |
andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL1A1 mRNA] andrographolide results in decreased expression of COL1A1 mRNA andrographolide inhibits the reaction [Acetaminophen results in increased expression of COL1A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:29355602 PMID:31706003 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
decreases expression multiple interactions |
EXP ISO |
andrographolide results in decreased expression of COL1A2 mRNA andrographolide inhibits the reaction [Acetaminophen results in increased expression of COL1A2 mRNA] |
CTD |
PMID:29355602 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
decreases expression multiple interactions |
ISO EXP |
andrographolide results in decreased expression of COL3A1 mRNA andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL3A1 mRNA] andrographolide inhibits the reaction [Acetaminophen results in increased expression of COL3A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein] |
CTD |
PMID:29355602 PMID:31706003 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
CRCT1 |
cysteine rich C-terminal 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CRCT1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:152,514,482...152,516,008
Ensembl chr 1:152,514,482...152,516,008
|
|
G |
CTNNB1 |
catenin beta 1 |
decreases expression multiple interactions |
EXP |
andrographolide results in decreased expression of CTNNB1 protein KYA1797K promotes the reaction [andrographolide results in decreased expression of CTNNB1 protein] |
CTD |
PMID:35917943 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions increases expression |
EXP |
[andrographolide co-treated with TNF protein] results in decreased expression of CXCL1 mRNA andrographolide results in increased expression of CXCL1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL13 |
C-X-C motif chemokine ligand 13 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CXCL13 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO EXP |
andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of CXCL2 protein] andrographolide results in increased expression of CXCL2 mRNA |
CTD |
PMID:32061742 PMID:35724838 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CXCL8 mRNA]; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of CXCL8 protein] |
CTD |
PMID:31128153 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions increases expression increases activity |
ISO |
[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA; [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 mRNA; [andrographolide co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A1 mRNA; Acetylcysteine affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Ascorbic Acid affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; beta-Naphthoflavone promotes the reaction [andrographolide results in increased expression of CYP1A1 mRNA]; Buthionine Sulfoximine promotes the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Glutathione affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Hydrogen Peroxide promotes the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; resveratrol inhibits the reaction [[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA] andrographolide results in increased activity of CYP1A1 protein |
CTD |
PMID:17825862 PMID:19737545 PMID:21094198 PMID:21963808 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
decreases expression multiple interactions increases expression |
EXP ISO |
andrographolide results in decreased expression of CYP1A2 mRNA andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] andrographolide results in increased expression of CYP1A2 mRNA [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA; [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA |
CTD |
PMID:17825862 PMID:19041297 PMID:19737545 PMID:20096675 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
multiple interactions |
ISO |
[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1B1 mRNA; andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:17825862 PMID:19737545 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2A7 |
cytochrome P450 family 2 subfamily A member 7 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of CYP2A4 mRNA beta-Naphthoflavone promotes the reaction [andrographolide results in increased expression of CYP2A4 mRNA] |
CTD |
PMID:19737545 |
|
NCBI chr19:40,875,439...40,882,231
Ensembl chr19:40,875,439...40,882,752
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
increases activity increases expression multiple interactions |
ISO |
andrographolide results in increased activity of CYP2B10 protein andrographolide results in increased expression of CYP2B10 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B10 mRNA |
CTD |
PMID:19737545 PMID:21094198 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2C18 |
cytochrome P450 family 2 subfamily C member 18 |
decreases expression |
ISO |
andrographolide results in decreased expression of CYP2C11 mRNA; andrographolide results in decreased expression of CYP2C11 protein |
CTD |
PMID:19041297 |
|
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
decreases expression |
EXP |
andrographolide results in decreased expression of CYP2C9 mRNA |
CTD |
PMID:19041297 |
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
decreases expression |
EXP |
andrographolide results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:19041297 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
CYP8B1 |
cytochrome P450 family 8 subfamily B member 1 |
increases expression |
ISO |
andrographolide results in increased expression of CYP8B1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
|
|
G |
DDC |
dopa decarboxylase |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of DDC mRNA andrographolide results in increased expression of DDC mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
andrographolide results in increased expression of DDIT3 protein |
CTD |
PMID:35724838 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DUSP10 |
dual specificity phosphatase 10 |
increases expression multiple interactions |
EXP |
andrographolide results in increased expression of DUSP10 mRNA; andrographolide results in increased expression of DUSP10 protein 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [andrographolide results in increased expression of DUSP10 mRNA]; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [andrographolide results in increased expression of DUSP10 protein]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of ATF2 protein modified form]]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; HMOX1 protein promotes the reaction [andrographolide results in increased expression of DUSP10 protein]; zinc protoporphyrin inhibits the reaction [andrographolide results in increased expression of DUSP10 mRNA]; zinc protoporphyrin inhibits the reaction [andrographolide results in increased expression of DUSP10 protein] |
CTD |
PMID:29165873 |
|
NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,701,424...221,742,089
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions increases expression |
EXP |
andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 mRNA]; andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 protein]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 mRNA]]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 protein]] andrographolide results in increased expression of EDN1 mRNA |
CTD |
PMID:27297870 PMID:29165873 PMID:35724838 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EGLN1 |
egl-9 family hypoxia inducible factor 1 |
multiple interactions increases expression |
EXP |
EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of VEGFA protein]; TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 mRNA]; TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 protein] andrographolide results in increased expression of EGLN1 mRNA; andrographolide results in increased expression of EGLN1 protein |
CTD |
PMID:21134392 PMID:27297870 |
|
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
|
|
G |
EGLN3 |
egl-9 family hypoxia inducible factor 3 |
increases expression |
EXP |
andrographolide results in increased expression of EGLN3 protein |
CTD |
PMID:27297870 |
|
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
|
|
G |
EID3 |
EP300 interacting inhibitor of differentiation 3 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of EID3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr12:104,303,739...104,305,205
Ensembl chr12:104,303,739...104,305,205
|
|
G |
ELANE |
elastase, neutrophil expressed |
multiple interactions |
ISO |
andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of ELANE protein] |
CTD |
PMID:32061742 |
|
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
|
|
G |
EZH2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
multiple interactions |
ISO EXP |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]] |
CTD |
PMID:31128153 |
|
NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions increases expression |
EXP |
[andrographolide co-treated with Cisplatin] promotes the reaction [FAS protein binds to FASLG protein]; [andrographolide co-treated with Cisplatin] results in increased expression of FAS mRNA; [andrographolide co-treated with Cisplatin] results in increased expression of FAS protein; andrographolide promotes the reaction [FAS protein binds to FASLG protein] andrographolide results in increased expression of FAS mRNA; andrographolide results in increased expression of FAS protein |
CTD |
PMID:24563380 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
multiple interactions increases expression |
EXP |
[andrographolide co-treated with Cisplatin] promotes the reaction [FAS protein binds to FASLG protein]; [andrographolide co-treated with Cisplatin] results in increased expression of FASLG mRNA; [andrographolide co-treated with Cisplatin] results in increased expression of FASLG protein; andrographolide promotes the reaction [FAS protein binds to FASLG protein] andrographolide results in increased expression of FASLG mRNA; andrographolide results in increased expression of FASLG protein |
CTD |
PMID:24563380 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FASN |
fatty acid synthase |
multiple interactions |
ISO |
andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein] |
CTD |
PMID:27475717 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of FLT1 mRNA |
CTD |
PMID:28651835 |
|
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein] |
CTD |
PMID:31706003 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
andrographolide results in decreased localization of and results in decreased activity of FOS protein |
CTD |
PMID:19426720 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression decreases expression multiple interactions |
ISO EXP |
andrographolide results in increased expression of GCLC mRNA; andrographolide results in increased expression of GCLC protein andrographolide results in decreased expression of GCLC mRNA [andrographolide co-treated with TNF protein] results in increased expression of GCLC mRNA andrographolide inhibits the reaction [Acetaminophen results in decreased expression of GCLC mRNA] |
CTD |
PMID:25110055 PMID:29355602 PMID:35724838 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
multiple interactions decreases expression increases expression |
ISO EXP |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GCLM mRNA; andrographolide inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA] andrographolide results in decreased expression of GCLM mRNA [andrographolide co-treated with TNF protein] results in increased expression of GCLM mRNA andrographolide results in increased expression of GCLM protein andrographolide results in increased expression of GCLM mRNA; andrographolide results in increased expression of GCLM protein |
CTD |
PMID:19737545 PMID:25110055 PMID:29355602 PMID:35724838 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
[polylactic acid-polyglycolic acid copolymer co-treated with andrographolide] inhibits the reaction [sodium arsenite results in increased activity of GPT protein] |
CTD |
PMID:26485141 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions decreases phosphorylation |
ISO EXP |
andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein] andrographolide results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:27475717 PMID:35917943 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSR |
glutathione-disulfide reductase |
increases activity |
ISO |
andrographolide results in increased activity of GSR protein |
CTD |
PMID:25110055 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTM2 |
glutathione S-transferase mu 2 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
|
|
G |
GSTM3 |
glutathione S-transferase mu 3 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of GSTM3 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
|
|
G |
GSTM4 |
glutathione S-transferase mu 4 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of GSTM4 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
|
|
G |
HDAC1 |
histone deacetylase 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of HDAC1 protein |
CTD |
PMID:28651835 |
|
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions decreases expression increases expression |
EXP |
[andrographolide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in increased ubiquitination of HIF1A protein; [andrographolide co-treated with cobaltous chloride] results in increased hydroxylation of HIF1A protein; andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]; andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; andrographolide inhibits the reaction [HIF1A protein binds to VEGFA promoter]; andrographolide results in decreased expression of and affects the localization of HIF1A protein; andrographolide results in decreased expression of and results in increased degradation of HIF1A protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in increased degradation of HIF1A protein]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; HMOX1 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; pyrazolanthrone inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]] andrographolide results in increased expression of HIF1A protein modified form |
CTD |
PMID:21134392 PMID:27297870 PMID:28651835 PMID:29165873 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression decreases expression multiple interactions |
ISO EXP |
andrographolide results in increased expression of HMOX1 mRNA; andrographolide results in increased expression of HMOX1 protein andrographolide results in decreased expression of HMOX1 mRNA andrographolide inhibits the reaction [Acetaminophen results in decreased expression of HMOX1 mRNA] [andrographolide co-treated with TNF protein] results in increased expression of HMOX1 mRNA; HMOX1 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; HMOX1 protein promotes the reaction [andrographolide results in increased expression of DUSP10 protein] |
CTD |
PMID:25110055 PMID:27297870 PMID:29165873 PMID:29355602 PMID:35724838 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HOTAIR |
HOX transcript antisense RNA |
multiple interactions |
ISO EXP |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of HOTAIR mRNA] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of HOTAIR mRNA]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of HOTAIR mRNA]] |
CTD |
PMID:31128153 |
|
NCBI chr12:53,962,312...53,974,954
Ensembl chr12:53,962,308...53,974,956
|
|
G |
HP |
haptoglobin |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of HP mRNA |
CTD |
PMID:19737545 |
|
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
|
|
G |
HPGD |
15-hydroxyprostaglandin dehydrogenase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of HPGD mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
[andrographolide co-treated with TNF protein] results in decreased expression of ICAM1 mRNA; andrographolide inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:35724838 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IKBKE |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of IKBKE mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:206,470,476...206,496,889
Ensembl chr 1:206,470,476...206,496,889
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP |
andrographolide inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; andrographolide inhibits the reaction [IL1B protein affects the localization of RELA protein]; andrographolide inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; andrographolide inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP ISO |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL6 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of HOTAIR mRNA]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of STAT3 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL6 protein]] andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of IL6 protein] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA]; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL6 protein] |
CTD |
PMID:31128153 PMID:32061742 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA]; andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:27475717 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
andrographolide results in decreased localization of and results in decreased activity of JUN protein |
CTD |
PMID:19426720 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KDR |
kinase insert domain receptor |
multiple interactions decreases expression |
EXP |
[andrographolide co-treated with KDR protein] inhibits the reaction [VEGFA protein binds to KDR protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein] andrographolide results in decreased expression of KDR mRNA |
CTD |
PMID:24814888 PMID:28651835 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of KEAP1 mRNA; andrographolide results in decreased expression of KEAP1 protein |
CTD |
PMID:29355602 PMID:35724838 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
KRT5 |
keratin 5 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of KRT5 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr12:52,514,575...52,520,394
Ensembl chr12:52,514,575...52,520,530
|
|
G |
MAFG |
MAF bZIP transcription factor G |
decreases expression |
EXP |
andrographolide results in decreased expression of MAFG mRNA |
CTD |
PMID:35724838 |
|
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K4 protein] |
CTD |
PMID:24814888 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K6 protein] |
CTD |
PMID:24814888 |
|
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
|
|
G |
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K7 protein] |
CTD |
PMID:24814888 |
|
NCBI chr19:7,903,877...7,914,478
Ensembl chr19:7,903,843...7,914,478
|
|
G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP3K5 protein] |
CTD |
PMID:24814888 |
|
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein] andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:24814888 PMID:27475717 PMID:31706003 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein] andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:24814888 PMID:27475717 PMID:31706003 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO EXP |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP2 mRNA] andrographolide results in decreased expression of MMP2 protein |
CTD |
PMID:31706003 PMID:35917943 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP7 |
matrix metallopeptidase 7 |
decreases expression multiple interactions |
EXP |
andrographolide results in decreased expression of MMP7 mRNA; andrographolide results in decreased expression of MMP7 protein andrographolide results in decreased expression of and results in decreased activity of MMP7 protein |
CTD |
PMID:19426720 PMID:35917943 |
|
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO EXP |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA] andrographolide results in decreased expression of MMP9 protein |
CTD |
PMID:31706003 PMID:35917943 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of MPO protein] |
CTD |
PMID:32061742 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MTA1 |
metastasis associated 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of MTA1 mRNA; andrographolide results in decreased expression of MTA1 protein |
CTD |
PMID:28651835 |
|
NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
EXP |
andrographolide results in decreased expression of MYC protein |
CTD |
PMID:35917943 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYO18B |
myosin XVIIIB |
decreases expression |
ISO |
andrographolide results in decreased expression of MYO18B mRNA |
CTD |
PMID:19737545 |
|
NCBI chr22:25,742,188...26,063,847
Ensembl chr22:25,742,144...26,031,045
|
|
G |
NECAB1 |
N-terminal EF-hand calcium binding protein 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of NECAB1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 8:90,791,775...90,959,393
Ensembl chr 8:90,791,741...90,959,393
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
increases activity multiple interactions decreases response to substance |
ISO EXP |
andrographolide results in increased activity of NFE2L2 protein NFE2L2 gene mutant form inhibits the reaction [andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]] NFE2L2 gene mutant form results in decreased susceptibility to andrographolide andrographolide results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]] |
CTD |
PMID:25110055 PMID:27297870 PMID:29355602 PMID:35724838 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
andrographolide inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; andrographolide inhibits the reaction [TNF protein affects the localization of NFKBIA protein] |
CTD |
PMID:35724838 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NFKBIE |
NFKB inhibitor epsilon |
increases expression |
EXP |
andrographolide results in increased expression of NFKBIE mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788
|
|
G |
NGB |
neuroglobin |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of NGB mRNA |
CTD |
PMID:19737545 |
|
NCBI chr14:77,265,483...77,271,206
Ensembl chr14:77,265,483...77,271,206
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression decreases expression multiple interactions |
ISO EXP |
andrographolide results in increased expression of NQO1 mRNA andrographolide results in decreased expression of NQO1 mRNA andrographolide results in increased expression of NQO1 protein [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of NQO1 mRNA; andrographolide promotes the reaction [Acetaminophen results in increased expression of NQO1 mRNA] |
CTD |
PMID:19737545 PMID:29355602 PMID:35724838 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
OLR1 |
oxidized low density lipoprotein receptor 1 |
increases expression |
EXP |
andrographolide results in increased expression of OLR1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138
|
|
G |
OR2AP1 |
olfactory receptor family 2 subfamily AP member 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of OR6C8 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr12:55,572,468...55,575,612
Ensembl chr12:55,572,468...55,575,612
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
andrographolide results in increased cleavage of PARP1 protein |
CTD |
PMID:35917943 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions decreases expression |
ISO EXP |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of PCNA protein] andrographolide results in decreased expression of PCNA protein |
CTD |
PMID:31706003 PMID:35917943 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PDGFB |
platelet derived growth factor subunit B |
increases expression |
EXP |
andrographolide results in increased expression of PDGFB mRNA |
CTD |
PMID:35724838 |
|
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
|
|
G |
PDZRN3 |
PDZ domain containing ring finger 3 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PDZRN3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 3:73,382,431...73,624,941
Ensembl chr 3:73,382,431...73,624,941
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of PECAM1 protein |
CTD |
PMID:28651835 |
|
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
|
|
G |
PHOSPHO1 |
phosphoethanolamine/phosphocholine phosphatase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of PHOSPHO1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr17:49,223,366...49,230,787
Ensembl chr17:49,223,366...49,230,787
|
|
G |
PLAU |
plasminogen activator, urokinase |
increases expression |
EXP |
andrographolide results in increased expression of PLAU mRNA |
CTD |
PMID:35724838 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PLSCR1 |
phospholipid scramblase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PLSCR1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 3:146,515,180...146,544,607
Ensembl chr 3:146,515,180...146,544,856
|
|
G |
POR |
cytochrome p450 oxidoreductase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of POR mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] |
CTD |
PMID:27475717 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PRKAG2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
increases expression |
EXP |
andrographolide results in increased expression of PRKAG2 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 7:151,556,127...151,877,115
Ensembl chr 7:151,556,124...151,877,214
|
|
G |
PTGR1 |
prostaglandin reductase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of PTGR1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
EXP |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:24814888 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RB1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
EXP |
andrographolide results in decreased phosphorylation of RB1 protein |
CTD |
PMID:18619950 |
|
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
andrographolide inhibits the reaction [IL1B protein affects the localization of RELA protein]; andrographolide inhibits the reaction [TNF protein affects the localization of RELA protein]; andrographolide results in decreased expression of and results in decreased localization of RELA protein; pyrrolidine dithiocarbamic acid promotes the reaction [andrographolide results in decreased expression of and results in decreased localization of RELA protein] |
CTD |
PMID:35724838 PMID:35917943 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
S100A4 |
S100 calcium binding protein A4 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [Bleomycin results in increased expression of S100A4 protein] |
CTD |
PMID:31706003 |
|
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
|
|
G |
SERPINA7 |
serpin family A member 7 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of SERPINA7 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr X:106,032,435...106,038,727
Ensembl chr X:106,032,435...106,038,727
|
|
G |
SLC1A4 |
solute carrier family 1 member 4 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of SLC1A4 mRNA andrographolide results in increased expression of SLC1A4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
|
|
G |
SLC3A2 |
solute carrier family 3 member 2 |
decreases expression |
EXP |
andrographolide results in decreased expression of SLC3A2 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
andrographolide results in increased expression of SLC7A11 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
SMAD2 |
SMAD family member 2 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:31706003 |
|
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
|
|
G |
SMAD3 |
SMAD family member 3 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:31706003 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SNAI1 |
snail family transcriptional repressor 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of SNAI1 protein |
CTD |
PMID:35917943 |
|
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
|
|
G |
SOD1 |
superoxide dismutase 1 |
increases expression |
ISO |
andrographolide results in increased expression of SOD1 mRNA; andrographolide results in increased expression of SOD1 protein |
CTD |
PMID:25110055 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of SPP1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SQSTM1 |
sequestosome 1 |
increases expression decreases expression |
EXP |
andrographolide results in increased expression of SQSTM1 protein andrographolide results in decreased expression of SQSTM1 mRNA |
CTD |
PMID:29355602 PMID:35724838 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SRXN1 |
sulfiredoxin 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of SRXN1 mRNA [andrographolide co-treated with TNF protein] results in increased expression of SRXN1 mRNA andrographolide results in decreased expression of SRXN1 mRNA andrographolide results in increased expression of SRXN1 protein andrographolide results in increased expression of SRXN1 mRNA |
CTD |
PMID:19737545 PMID:35724838 |
|
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
decreases activity multiple interactions |
EXP ISO |
andrographolide results in decreased activity of STAT3 protein andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of STAT3 protein] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of STAT3 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of STAT3 protein]] |
CTD |
PMID:23845849 PMID:31128153 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STEAP4 |
STEAP4 metalloreductase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of STEAP4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 7:88,270,892...88,306,894
Ensembl chr 7:88,270,892...88,306,894
|
|
G |
TAP1 |
transporter 1, ATP binding cassette subfamily B member |
increases expression |
EXP |
andrographolide results in increased expression of TAP1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
|
|
G |
TAS2R50 |
taste 2 receptor member 50 |
multiple interactions |
EXP |
andrographolide binds to and results in increased activity of TAS2R50 protein |
CTD |
PMID:19817411 |
|
NCBI chr12:10,985,913...10,986,912
Ensembl chr12:10,985,913...10,986,912
|
|
G |
TDO2 |
tryptophan 2,3-dioxygenase |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of TDO2 mRNA andrographolide results in increased expression of TDO2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:155,903,696...155,920,406
Ensembl chr 4:155,854,738...155,920,406
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
decreases expression multiple interactions |
EXP ISO |
andrographolide results in decreased expression of TGFB1 protein andrographolide inhibits the reaction [TGFB1 protein results in decreased cleavage of CASP3 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP2 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of PCNA protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] andrographolide inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein] TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 mRNA]; TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 protein] |
CTD |
PMID:21134392 PMID:31706003 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
THBS1 |
thrombospondin 1 |
multiple interactions decreases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of THBS1 mRNA andrographolide results in decreased expression of THBS1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 mRNA] |
CTD |
PMID:31706003 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TMPRSS11F |
transmembrane serine protease 11F |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of TMPRSS11F mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:68,053,198...68,129,869
Ensembl chr 4:68,053,198...68,129,869
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
andrographolide inhibits the reaction [Copper Sulfate results in increased expression of TNF protein]; andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein] [andrographolide co-treated with TNF protein] results in decreased expression of BIRC3 mRNA; [andrographolide co-treated with TNF protein] results in decreased expression of CXCL1 mRNA; [andrographolide co-treated with TNF protein] results in decreased expression of ICAM1 mRNA; [andrographolide co-treated with TNF protein] results in decreased expression of TNFAIP3 mRNA; [andrographolide co-treated with TNF protein] results in increased expression of GCLC mRNA; [andrographolide co-treated with TNF protein] results in increased expression of GCLM mRNA; [andrographolide co-treated with TNF protein] results in increased expression of HMOX1 mRNA; [andrographolide co-treated with TNF protein] results in increased expression of SRXN1 mRNA; andrographolide inhibits the reaction [TNF protein affects the localization of NFKBIA protein]; andrographolide inhibits the reaction [TNF protein affects the localization of RELA protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:20946909 PMID:32061742 PMID:35724838 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFAIP3 |
TNF alpha induced protein 3 |
multiple interactions increases expression |
EXP |
[andrographolide co-treated with TNF protein] results in decreased expression of TNFAIP3 mRNA; andrographolide inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] andrographolide results in increased expression of TNFAIP3 mRNA; andrographolide results in increased expression of TNFAIP3 protein |
CTD |
PMID:35724838 |
|
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
|
|
G |
TNFRSF9 |
TNF receptor superfamily member 9 |
increases expression |
EXP |
andrographolide results in increased expression of TNFRSF9 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions increases expression |
EXP |
andrographolide results in increased expression of and results in increased phosphorylation of TP53 protein; Fluorouracil promotes the reaction [andrographolide results in increased expression of TP53] |
CTD |
PMID:18619950 PMID:19097688 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TRIB3 |
tribbles pseudokinase 3 |
decreases expression |
EXP |
andrographolide results in decreased expression of TRIB3 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of TXNRD1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of UGT1A6 mRNA andrographolide results in increased expression of UGT1A6 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions increases expression |
ISO EXP |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of VCAM1 mRNA andrographolide results in increased expression of VCAM1 mRNA |
CTD |
PMID:19737545 PMID:35724838 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions decreases expression |
EXP |
[andrographolide co-treated with KDR protein] inhibits the reaction [VEGFA protein binds to KDR protein]; andrographolide inhibits the reaction [HIF1A protein binds to VEGFA promoter]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K4 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K6 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K7 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP3K5 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of RAF1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in decreased expression of VEGFA mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in decreased expression of VEGFA protein]; EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of VEGFA protein]; pyrazolanthrone inhibits the reaction [andrographolide results in decreased expression of VEGFA mRNA]; pyrazolanthrone inhibits the reaction [andrographolide results in decreased expression of VEGFA protein] andrographolide results in decreased expression of VEGFA mRNA; andrographolide results in decreased expression of VEGFA protein |
CTD |
PMID:21134392 PMID:24814888 PMID:28651835 PMID:35724838 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VIL1 |
villin 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of VIL1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:218,419,123...218,453,295
Ensembl chr 2:218,419,121...218,453,295
|
|
G |
VIM |
vimentin |
multiple interactions decreases expression |
ISO EXP |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of VIM mRNA; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein] andrographolide results in decreased expression of VIM protein andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein]] |
CTD |
PMID:19737545 PMID:31128153 PMID:35917943 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
decreases expression |
EXP |
andrographolide results in decreased expression of XIAP protein |
CTD |
PMID:23845849 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
|
|
G |
ZFAND2A |
zinc finger AN1-type containing 2A |
decreases expression |
EXP |
andrographolide results in decreased expression of ZFAND2A mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 7:1,148,850...1,160,196
Ensembl chr 7:1,152,071...1,160,759
|
|
G |
ZG16B |
zymogen granule protein 16B |
decreases expression multiple interactions |
ISO |
andrographolide results in decreased expression of SBPL mRNA [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of SBPL mRNA |
CTD |
PMID:19737545 |
|
NCBI chr16:2,830,303...2,832,276
Ensembl chr16:2,830,253...2,839,585
|
|